SERF Protein Is a Direct Modifier of Amyloid Fiber Assembly

Cell Reports

Volumn 2, Issue 2, 2012, Pages 358-371

  Falsone, S Fabio ^a,b   Meyer, N Helge ^b   Schrank, Evelyne ^b   Leitinger, Gerd ^a   Pham, Chi L L ^c   Fodero Tavoletti, Michelle T ^c   Holmberg, Mats ^d   Dulle, Martin ^b   Scicluna, Benjamin ^c   Gesslbauer, Bernd ^b   Rückert, Hanna Marie ^b   Wagner, Gabriel E ^b   Merle, David A ^a,b   Nollen, Ellen A ^d   Kungl, Andreas J ^b   Hill, Andrew F ^c   Cappai, Roberto ^c   Zangger, Klaus ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; AMYLOID PROTEIN; HYBRID PROTEIN; SERF PROTEIN; SERF1A ALPHA SYNUCLEIN COMPLEX; SERF1A PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; BIOPHYSICS; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; IN VITRO STUDY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION;

ALPHA-SYNUCLEIN; AMYLOID; ANIMALS; HUMANS; MICE; NERVE TISSUE PROTEINS; SOLUBILITY; SWINE;

EID: 84865722715     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.06.012     Document Type: Article

References (43)

1. Bagriantsev S.N., Kushnirov V.V., Liebman S.W. Analysis of amyloid aggregates using agarose gel electrophoresis. Methods Enzymol. 2006, 412:33-48.
2. Bertoncini C.W., Jung Y.S., Fernandez C.O., Hoyer W., Griesinger C., Jovin T.M., Zweckstetter M. Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc. Natl. Acad. Sci. USA 2005, 102:1430-1435.
3. Breydo L., Makarava N., Baskakov I.V. Methods for conversion of prion protein into amyloid fibrils. Methods Mol. Biol. 2008, 459:105-115.
4. Buchner J., Grallert H., Jakob U. Analysis of chaperone function using citrate synthase as nonnative substrate protein. Methods Enzymol. 1998, 290:323-338.
5. Cappai R., Leck S.L., Tew D.J., Williamson N.A., Smith D.P., Galatis D., Sharples R.A., Curtain C.C., Ali F.E., Cherny R.A., et al. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. FASEB J. 2005, 19:1377-1379.
6. Chandra S., Chen X., Rizo J., Jahn R., Südhof T.C. A broken alpha -helix in folded alpha -Synuclein. J. Biol. Chem. 2003, 278:15313-15318.
7. Chiti F., Dobson C.M. Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75:333-366.
8. Dedmon M.M., Lindorff-Larsen K., Christodoulou J., Vendruscolo M., Dobson C.M. Mapping long-range interactions in alpha-synuclein using spin-label NMR and ensemble molecular dynamics simulations. J. Am. Chem. Soc. 2005, 127:476-477.
9. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6:277-293.
10. Ehrnhoefer D.E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., Engemann S., Pastore A., Wanker E.E. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 2008, 15:558-566.
11. Eichner T., Radford S.E. A diversity of assembly mechanisms of a generic amyloid fold. Mol. Cell 2011, 43:8-18.
12. Falsone S.F., Kungl A.J., Rek A., Cappai R., Zangger K. The molecular chaperone Hsp90 modulates intermediate steps of amyloid assembly of the Parkinson-related protein alpha-synuclein. J. Biol. Chem. 2009, 284:31190-31199.
13. Fernández C.O., Hoyer W., Zweckstetter M., Jares-Erijman E.A., Subramaniam V., Griesinger C., Jovin T.M. NMR of alpha-synuclein-polyamine complexes elucidates the mechanism and kinetics of induced aggregation. EMBO J. 2004, 23:2039-2046.
14. Glabe C.G. Common mechanisms of amyloid oligomer pathogenesis in degenerative disease. Neurobiol. Aging 2006, 27:570-575.
15. Hartl F.U., Bracher A., Hayer-Hartl M. Molecular chaperones in protein folding and proteostasis. Nature 2011, 475:324-332.
16. Hoyer W., Cherny D., Subramaniam V., Jovin T.M. Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry 2004, 43:16233-16242.
17. Johnson B.A., Blevins R.A. NMRView: a computer program for the visualization and analysis of NMR data. J. Biomol. NMR 1994, 4:603-614.
18. Kim H.Y., Cho M.K., Kumar A., Maier E., Siebenhaar C., Becker S., Fernandez C.O., Lashuel H.A., Benz R., Lange A., Zweckstetter M.J. Structural properties of pore-forming oligomers of alpha-synuclein. J. Am. Chem. Soc. 2009, 131:17482-17489.
19. Koppel D.E. Analysis of macromolecular polydispersity in intensity correlation spectroscopy: the method of cumulants. J. Chem. Phys. 1972, 57:4814-4820.
20. Lakowicz J.R. Fluorescence anisotropy. Principles of Fluorescence Spectroscopy 1999, 308-310. Springer, New York.
21. Lashuel H.A., Petre B.M., Wall J., Simon M., Nowak R.J., Walz T., Lansbury P.T. Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J. Mol. Biol. 2002, 322:1089-1102.
22. LeVine H. Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999, 309:274-284.
23. Levitan K., Chereau D., Cohen S.I., Knowles T.P., Dobson C.M., Fink A.L., Anderson J.P., Goldstein J.M., Millhauser G.L. Conserved C-terminal charge exerts a profound influence on the aggregation rate of α-synuclein. J. Mol. Biol. 2011, 411:329-333.
24. Lu J., Wong J.J., Edwards R.A., Manchak J., Frost L.S., Glover J.N. Structural basis of specific TraD-TraM recognition during F plasmid-mediated bacterial conjugation. Mol. Microbiol. 2008, 70:89-99.
25. McClendon S., Rospigliosi C.C., Eliezer D. Charge neutralization and collapse of the C-terminal tail of alpha-synuclein at low pH. Protein Sci. 2009, 18:1531-1540.
26. Morris A.M., Watzky M.A., Finke R.G. Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim. Biophys. Acta 2009, 1794:375-397.
27. Murray I.V., Giasson B.I., Quinn S.M., Koppaka V., Axelsen P.H., Ischiropoulos H., Trojanowski J.Q., Lee V.M. Role of alpha-synuclein carboxy-terminus on fibril formation in vitro. Biochemistry 2003, 42:8530-8540.
28. Nielsen M.S., Vorum H., Lindersson E., Jensen P.H. Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization. J. Biol. Chem. 2001, 276:22680-22684.
29. Pham C.L., Leong S.L., Ali F.E., Kenche V.B., Hill A.F., Gras S.L., Barnham K.J., Cappai R. Dopamine and the dopamine oxidation product 5,6-dihydroxylindole promote distinct on-pathway and off-pathway aggregation of alpha-synuclein in a pH-dependent manner. J. Mol. Biol. 2009, 387:771-785.
30. Rasia R.M., Bertoncini C.W., Marsh D., Hoyer W., Cherny D., Zweckstetter M., Griesinger C., Jovin T.M., Fernández C.O. Structural characterization of copper(II) binding to alpha-synuclein: Insights into the bioinorganic chemistry of Parkinson's disease. Proc. Natl. Acad. Sci. USA 2005, 102:4294-4299.
31. Scheibel T., Weikl T., Buchner J. Two chaperone sites in Hsp90 differing in substrate specificity and ATP dependence. Proc. Natl. Acad. Sci. USA 1998, 95:1495-1499.
32. Spillantini M.G., Crowther R.A., Jakes R., Hasegawa M., Goedert M. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Natl. Acad. Sci. USA 1998, 95:6469-6473.
33. Sreerama N., Venyaminov S.Y., Woody R.W. Estimation of the number of alpha-helical and beta-strand segments in proteins using circular dichroism spectroscopy. Protein Sci. 1999, 8:370-380.
34. Tompa P. Hydrodynamic techniques. Structure and Function of Intrinsically Disordered Proteins 2010, 43-84. CRC Press, Boca Raton, FL.
35. Ullman O., Fisher C.K., Stultz C.M. Explaining the structural plasticity of α-synuclein. J. Am. Chem. Soc. 2011, 133:19536-19546.
36. Uversky V.N. Use of fast protein size-exclusion liquid chromatography to study the unfolding of proteins which denature through the molten globule. Biochemistry 1993, 32:13288-13298.
37. Uversky V.N., Li J., Fink A.L. Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure. J. Biol. Chem. 2001, 276:44284-44296.
38. van Ham T.J., Holmberg M.A., van der Goot A.T., Teuling E., Garcia-Arencibia M., Kim H.E., Du D., Thijssen K.L., Wiersma M., Burggraaff R., et al. Identification of MOAG-4/SERF as a regulator of age-related proteotoxicity. Cell 2010, 142:601-612.
39. Wacker J.L., Zareie M.H., Fong H., Sarikaya M., Muchowski P.J. Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat. Struct. Mol. Biol. 2004, 11:1215-1222.
40. Wang W., Perovic I., Chittuluru J., Kaganovich A., Nguyen L.T., Liao J., Auclair J.R., Johnson D., Landeru A., Simorellis A.K., et al. A soluble α-synuclein construct forms a dynamic tetramer. Proc. Natl. Acad. Sci. USA 2011, 108:17797-17802.
41. Welker S., Rudolph B., Frenzel E., Hagn F., Liebisch G., Schmitz G., Scheuring J., Kerth A., Blume A., Weinkauf S., et al. Hsp12 is an intrinsically unstructured stress protein that folds upon membrane association and modulates membrane function. Mol. Cell 2010, 39:507-520.
42. Whitmore L., Wallace B.A. Protein secondary structure analyses from circular dichroism spectroscopy: methods and reference databases. Biopolymers 2008, 89:392-400.
43. Yagi H., Kusaka E., Hongo K., Mizobata T., Kawata Y. Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases. J. Biol. Chem. 2005, 280:38609-38616.